Unitedhealth Group INC Form 4 insider transactions

UnitedHealth Group Director John H. Noseworthy was granted 288 deferred stock units as part of his regular quarterly compensation, increasing his beneficial ownership to 6,393 shares.

UnitedHealth Group director Charles D. Baker was granted 269 deferred stock units as part of his regular quarterly compensation, increasing his beneficial ownership to 1,248 shares.

UnitedHealth Group director Valerie Montgomery Rice MD was granted 288 deferred stock units as part of her regular quarterly compensation, increasing her beneficial ownership to 6,587 shares.

UnitedHealth Group Director Kristen Gil reported the acquisition of 173 shares of common stock as part of her regular quarterly compensation for service as a director.

UnitedHealth Group Inc. Director Valerie C. Montgomery Rice M.D. acquired 43 shares of common stock through dividend equivalents on vested deferred stock units.

Patrick H. Conway, CEO of Optum at UnitedHealth Group, acquired 73.058 shares of common stock through dividend equivalents on June 24, 2025, increasing his total beneficial ownership.

UnitedHealth Group's Chief Accounting Officer, Thomas E. Roos, has reported the acquisition of 25.252 shares of common stock as dividend equivalents on outstanding restricted stock units.

UnitedHealth Group Director Michele J. Hooper acquired 266 shares of common stock through dividend equivalents on vested deferred stock units, increasing her beneficial ownership to 40,306 shares.

UnitedHealth Group's CEO and Director, Stephen J. Hemsley, reported the acquisition of 55 shares of common stock as dividend equivalents on vested deferred stock units, effective June 24, 2025, under a Rule 10b5-1 plan.

UnitedHealth Group Inc. Director Kristen Gil reported a planned acquisition of 7 shares of common stock as dividend equivalents on vested deferred stock units, scheduled for June 24, 2025, under a Rule 10b5-1 plan.

UnitedHealth Group Director John H. Noseworthy acquired 42 shares of common stock as dividend equivalents on vested deferred stock units, increasing his total beneficial ownership to 6,105 shares.

Paul R. Garcia, a Director at UnitedHealth Group Inc. (UNH), has acquired 11 shares of common stock through dividend equivalents on vested deferred stock units.

Christopher R. Zaetta, EVP & Chief Legal Officer of UnitedHealth Group Inc., acquired 48.038 shares of common stock through dividend equivalents on outstanding restricted stock units.

UnitedHealth Group Inc. Director Charles D. Baker reported the acquisition of 8 shares of common stock as dividend equivalents on vested deferred stock units, increasing his total beneficial ownership to 979 shares.

John F. Rex, President and CFO of UnitedHealth Group Inc., reported the acquisition of 131.931 shares of common stock as dividend equivalents on outstanding restricted stock units.

Timothy J. Noel, Chief Executive Officer of UnitedHealthcare, has increased his beneficial ownership in UnitedHealth Group Inc. by acquiring 47.823 shares of common stock through dividend equivalents on restricted stock units.

UnitedHealth Group's EVP & Chief People Officer, Erin McSweeney, reported the acquisition of 41.607 shares of common stock through dividend equivalents on outstanding restricted stock units.

UnitedHealth Group Director Timothy Patrick Flynn acquired 66 shares of common stock on June 24, 2025, through dividend equivalents on vested deferred stock units.

Frederick William McNabb III, a Director at UnitedHealth Group Inc., has increased his beneficial ownership of common stock by 53 shares through dividend equivalents.

Patrick Hugh Conway, Chief Executive Officer of Optum, a UnitedHealth Group subsidiary, reported the sale of 589 shares of UnitedHealth Group common stock at $305 per share.

Erin McSweeney, EVP & Chief People Officer at UnitedHealth Group, reported a disposition of company common stock to cover tax withholding obligations.

Patrick H. Conway, Chief Executive Officer of Optum, a UnitedHealth Group subsidiary, reported the disposition of common stock shares to cover tax obligations related to equity awards.

UnitedHealth Group's EVP & Chief Legal Officer, Christopher R. Zaetta, reported the disposition of 115.129 shares of common stock to cover tax withholding obligations.

UnitedHealth Group's President and CFO, John F. Rex, reported the disposition of 29.502 shares of common stock on June 3, 2025, at a price of $301.22 per share, primarily for tax withholding.

Patrick Hugh Conway, CEO of Optum, a UnitedHealth Group subsidiary, has been granted 1,641 restricted stock units and 6,550 non-qualified stock options, aligning his interests with the company's long-term performance.

CEO of UnitedHealth Group, Stephen Hemsley, reports a gift of shares and transfers to trusts in a recent SEC filing.

John F. Rex, President & CFO of UnitedHealth Group, reports purchasing 17,175 shares of UNH common stock at a weighted average price of $291.1161 on May 16, 2025.

Stephen Hemsley, CEO of UnitedHealth Group, reports the acquisition of 86,700 shares of common stock and a grant of 602,773 non-qualified stock options.

Director Timothy Patrick Flynn of UnitedHealth Group Incorporated acquired 1,533 shares of common stock at a price of $320.8 on May 14, 2025.

Director Kristen Gil reports purchasing 3,700 shares of UnitedHealth Group (UNH) common stock at $271.17 per share on May 15, 2025.